About this trial
The overall objective is to establish the first-of-its-kind longitudinal cohort of pregnant women, biological fathers/partners and offspring from pregnancies achieved by frozen embryo transfer (FET), fresh-embryo transfer (fresh ET) and naturally conceived (NC) to investigate maternal cardiometabolic profiles, fetal growth patterns and placental function during pregnancy as well as metabolic and endocrine health in the offspring. Additionally, the aim is to explore genetic and epigenetic patterns in placenta, fetus and parents. As secondary objectives, the investigator group will examine telomere length and minipuberty hormones in children born after FET, fresh-ET and NC.
Eligibility criteria
Qualifiers
None
Disqualifiers
Maternal pregestational diabetes type 1 or 2
Non-singleton pregnancies
Maternal pregestational BMI > 35 kg/m2
Severe maternal co-morbidity
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Rigshospitalet, Denmark
Lead sponsor
Herlev Hospital
Collaborator